Keywords: chmp, gives, nod, lilly, alimta, locally-advanced, nsclc

CHMP gives nod for Lilly's Alimta in locally-advanced NSCLC

Article | 04 June 2009

Print This

US drug major Eli Lilly's Alimta (pemetrexed for injection) has been recommended for approval by the European Medicines Agency's (EMEA) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in